Emel Isiktas Sayilar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emel Isiktas Sayilar has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Alparslan Ersoy
Department of Nephrology, Faculty of Medicine, Bursa Uludag University, 16059 Bursa, Türkiye
4 shared publications - İhSan Ergun
Transplantation Unit, Memorial Ankara Hospital, Mevlana Boulevard. 1422/4, Ankara, Çankaya, 06520, Türkiye
3 shared publications Yavuz Ayar
3 shared publications- Yavuz Ayar
University of Health Sciences, Bursa City Hospital, Department of Nephrology, Bursa, Türkiye
3 shared publications Alparslan Ersoy
2 shared publications- Ceyla Konca Degertekin
Ufuk Üniversitesi
2 shared publications
Latest Publications
- 27 October 2026
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 89 (4) , 279-285
SEROLOGICAL AND MOLECULAR EVALUATION OF HUMAN HERPESVIRUS 8 IN KIDNEY TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY FROM TÜRKİYE
Objective: This study assessed the seroprevalence and molecular detection of human herpesvirus 8 (HHV-8) in kidney transplant recipients compared with healthy blood donors.Materials and Methods: This study included 112 kidney transplant recipients attending the Nephrology Clinic at Ankara Etlik City Hospital and 200 healthy blood donors. Serum samples were tested for HHV-8 IgG using enzyme-linked immunosorbent assay (ELISA), and plasma samples were analyzed for HHV-8 DNA by real-time polymerase chain reaction (PCR).Results: HHV-8 IgG positivity was observed in 9.8% (11/112) of kidney transplant recipients and 6.5% (13/200) of blood donors (p=0.294). The highest HHV-8 IgG seropositivity among kidney transplant recipients was observed in the 18-30 years age group (26.7%), whereas the corresponding rate in healthy blood donors was 8.5%. No statistically significant sex-related differences in HHV-8 seropositivity were identified in either group. A generalized linear model including study group, age category, and their interaction showed no significant overall interaction between study group and age category with respect to HHV-8 IgG seropositivity (p=0.095). HHV-8 DNA was not detected in any of the samples analyzed by real-time PCR.Conclusion: HHV-8 seroprevalence was comparable between kidney transplant recipients and blood donors, with no evidence of active HHV-8 viremia in either group. Although numerical differences were observed in age-stratified analyses, no significant interaction between study group and age category was identified. These findings should be interpreted cautiously and considered exploratory. Larger prospective multicenter studies are warranted to clarify the epidemiology and clinical significance of HHV-8 infection in kidney transplant recipients.
- 27 October 2026
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 89 (4) , 279-285
SEROLOGICAL AND MOLECULAR EVALUATION OF HUMAN HERPESVIRUS 8 IN KIDNEY TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY FROM TÜRKİYE
Objective: This study assessed the seroprevalence and molecular detection of human herpesvirus 8 (HHV-8) in kidney transplant recipients compared with healthy blood donors.Materials and Methods: This study included 112 kidney transplant recipients attending the Nephrology Clinic at Ankara Etlik City Hospital and 200 healthy blood donors. Serum samples were tested for HHV-8 IgG using enzyme-linked immunosorbent assay (ELISA), and plasma samples were analyzed for HHV-8 DNA by real-time polymerase chain reaction (PCR).Results: HHV-8 IgG positivity was observed in 9.8% (11/112) of kidney transplant recipients and 6.5% (13/200) of blood donors (p=0.294). The highest HHV-8 IgG seropositivity among kidney transplant recipients was observed in the 18-30 years age group (26.7%), whereas the corresponding rate in healthy blood donors was 8.5%. No statistically significant sex-related differences in HHV-8 seropositivity were identified in either group. A generalized linear model including study group, age category, and their interaction showed no significant overall interaction between study group and age category with respect to HHV-8 IgG seropositivity (p=0.095). HHV-8 DNA was not detected in any of the samples analyzed by real-time PCR.Conclusion: HHV-8 seroprevalence was comparable between kidney transplant recipients and blood donors, with no evidence of active HHV-8 viremia in either group. Although numerical differences were observed in age-stratified analyses, no significant interaction between study group and age category was identified. These findings should be interpreted cautiously and considered exploratory. Larger prospective multicenter studies are warranted to clarify the epidemiology and clinical significance of HHV-8 infection in kidney transplant recipients.
- Open Access
- 7 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3232
Utility of Deceased Expanded-Criteria Donors in Kidney Transplantation: A Single-Center Experience
Purpose: The success of solid organ transplantation and the consequent increase in the patients on the waiting list has led to an increased utilization of donor kidneys with a high kidney donor profile index (KDPI)/expanded criteria. In our study, patients who underwent transplantation based on the standard and expanded donor criteria were compared in terms of factors affecting graft survival. Data of patients who underwent transplantation from cadavers with standard and extended criteria (SCD, ECD) between 01 July 2011 and 30 June 2016 were evaluated retrospectively. Donor characteristics, treatment type, response and graft characteristics, 1st-, 3rd-, and 5th-year graft survival, and acute rejection rates were analyzed retrospectively. Recent findings: In terms of the causes of death, cerebrovascular accidents were more common in the ECD group (p < 0.001). Hypertension and diabetes were more common in both donor groups and were detected more frequently in recipients in the ECD group (p < 0.001). The absence of mycophenolate mofetil (MMF) use and the presence of an acute rejection attack adversely affected graft survival at the end of the 1st, 3rd, and 5th years. Summary: The utilization of expanded criteria donors is widespread. Appropriate monitoring of patients undergoing immunosuppressive therapy, especially using mycophenolate mofetil (MMF) and the presence of acute rejection, affect graft survival.
- 7 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3232
Open AccessUtility of Deceased Expanded-Criteria Donors in Kidney Transplantation: A Single-Center Experience
Purpose: The success of solid organ transplantation and the consequent increase in the patients on the waiting list has led to an increased utilization of donor kidneys with a high kidney donor profile index (KDPI)/expanded criteria. In our study, patients who underwent transplantation based on the standard and expanded donor criteria were compared in terms of factors affecting graft survival. Data of patients who underwent transplantation from cadavers with standard and extended criteria (SCD, ECD) between 01 July 2011 and 30 June 2016 were evaluated retrospectively. Donor characteristics, treatment type, response and graft characteristics, 1st-, 3rd-, and 5th-year graft survival, and acute rejection rates were analyzed retrospectively. Recent findings: In terms of the causes of death, cerebrovascular accidents were more common in the ECD group (p < 0.001). Hypertension and diabetes were more common in both donor groups and were detected more frequently in recipients in the ECD group (p < 0.001). The absence of mycophenolate mofetil (MMF) use and the presence of an acute rejection attack adversely affected graft survival at the end of the 1st, 3rd, and 5th years. Summary: The utilization of expanded criteria donors is widespread. Appropriate monitoring of patients undergoing immunosuppressive therapy, especially using mycophenolate mofetil (MMF) and the presence of acute rejection, affect graft survival.
- Open Access
- 12 July 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (3) , 163-170
Evaluation of acute kidney injury patients in intensive care unit and determining effects of hemodialysis on sepsis
Aim: Sepsis-associated acute kidney injury (AKI) is a frequent complication of critically ill patients, and results need for renal replacement therapy (RRT). We aimed to investigate the difference in vital signs, hemodynamic parameters, and laboratory values after receiving RRT in the AKI patients with/without sepsis. Also, we examined the different renal injury grading systems relationships used in intensive care units (ICU). Methods: RRT-treated patients due to AKI were enrolled. Patients were divided into two groups by using Sepsis-2 criteria (2012); whether there is sepsis or not. Acute physiology and chronic health evaluation II (APACHE II) scores, 28th and 90th day mortality recorded. RIFLE classes, renal sequential organ failure assessment (SOFA) scores, and kidney disease: improving global outcomes (KDIGO), stages were also calculated. Patients’ Glasgow Coma Scale (GCS), vital parameters, laboratory values, Horowitz rates, vasopressor/inotropic agent requirements at RRT start, 12th and 24th hours were recorded. Results: 153 patients were included in the study, and 93 were septic. APACHE II score and 28th day mortality were significantly higher in Group Sepsis. Advanced age was found to be associated with 90th day mortality. Both in two groups many parameters such as acidosis, Horowitz ratio, and GCS improved after RRT initiation. When renal scoring systems were compared with each other KDIGO was associated with the RIFLE classification and renal SOFA. Conclusion: Many improvements were observed in all AKI patients after RRT but in septic patients, oxygenation and GCS showed better improvement. The mortality rate increased when AKI got complicated with sepsis.
- 12 July 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (3) , 163-170
Open AccessEvaluation of acute kidney injury patients in intensive care unit and determining effects of hemodialysis on sepsis
Aim: Sepsis-associated acute kidney injury (AKI) is a frequent complication of critically ill patients, and results need for renal replacement therapy (RRT). We aimed to investigate the difference in vital signs, hemodynamic parameters, and laboratory values after receiving RRT in the AKI patients with/without sepsis. Also, we examined the different renal injury grading systems relationships used in intensive care units (ICU). Methods: RRT-treated patients due to AKI were enrolled. Patients were divided into two groups by using Sepsis-2 criteria (2012); whether there is sepsis or not. Acute physiology and chronic health evaluation II (APACHE II) scores, 28th and 90th day mortality recorded. RIFLE classes, renal sequential organ failure assessment (SOFA) scores, and kidney disease: improving global outcomes (KDIGO), stages were also calculated. Patients’ Glasgow Coma Scale (GCS), vital parameters, laboratory values, Horowitz rates, vasopressor/inotropic agent requirements at RRT start, 12th and 24th hours were recorded. Results: 153 patients were included in the study, and 93 were septic. APACHE II score and 28th day mortality were significantly higher in Group Sepsis. Advanced age was found to be associated with 90th day mortality. Both in two groups many parameters such as acidosis, Horowitz ratio, and GCS improved after RRT initiation. When renal scoring systems were compared with each other KDIGO was associated with the RIFLE classification and renal SOFA. Conclusion: Many improvements were observed in all AKI patients after RRT but in septic patients, oxygenation and GCS showed better improvement. The mortality rate increased when AKI got complicated with sepsis.
- Open Access
- 12 July 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (3) , 163-170
Evaluation of acute kidney injury patients in intensive care unit and determining effects of hemodialysis on sepsis
Aim: Sepsis-associated acute kidney injury (AKI) is a frequent complication of critically ill patients, and results need for renal replacement therapy (RRT). We aimed to investigate the difference in vital signs, hemodynamic parameters, and laboratory values after receiving RRT in the AKI patients with/without sepsis. Also, we examined the different renal injury grading systems relationships used in intensive care units (ICU). Methods: RRT-treated patients due to AKI were enrolled. Patients were divided into two groups by using Sepsis-2 criteria (2012); whether there is sepsis or not. Acute physiology and chronic health evaluation II (APACHE II) scores, 28th and 90th day mortality recorded. RIFLE classes, renal sequential organ failure assessment (SOFA) scores, and kidney disease: improving global outcomes (KDIGO), stages were also calculated. Patients’ Glasgow Coma Scale (GCS), vital parameters, laboratory values, Horowitz rates, vasopressor/inotropic agent requirements at RRT start, 12th and 24th hours were recorded. Results: 153 patients were included in the study, and 93 were septic. APACHE II score and 28th day mortality were significantly higher in Group Sepsis. Advanced age was found to be associated with 90th day mortality. Both in two groups many parameters such as acidosis, Horowitz ratio, and GCS improved after RRT initiation. When renal scoring systems were compared with each other KDIGO was associated with the RIFLE classification and renal SOFA. Conclusion: Many improvements were observed in all AKI patients after RRT but in septic patients, oxygenation and GCS showed better improvement. The mortality rate increased when AKI got complicated with sepsis.
- 12 July 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (3) , 163-170
Open AccessEvaluation of acute kidney injury patients in intensive care unit and determining effects of hemodialysis on sepsis
Aim: Sepsis-associated acute kidney injury (AKI) is a frequent complication of critically ill patients, and results need for renal replacement therapy (RRT). We aimed to investigate the difference in vital signs, hemodynamic parameters, and laboratory values after receiving RRT in the AKI patients with/without sepsis. Also, we examined the different renal injury grading systems relationships used in intensive care units (ICU). Methods: RRT-treated patients due to AKI were enrolled. Patients were divided into two groups by using Sepsis-2 criteria (2012); whether there is sepsis or not. Acute physiology and chronic health evaluation II (APACHE II) scores, 28th and 90th day mortality recorded. RIFLE classes, renal sequential organ failure assessment (SOFA) scores, and kidney disease: improving global outcomes (KDIGO), stages were also calculated. Patients’ Glasgow Coma Scale (GCS), vital parameters, laboratory values, Horowitz rates, vasopressor/inotropic agent requirements at RRT start, 12th and 24th hours were recorded. Results: 153 patients were included in the study, and 93 were septic. APACHE II score and 28th day mortality were significantly higher in Group Sepsis. Advanced age was found to be associated with 90th day mortality. Both in two groups many parameters such as acidosis, Horowitz ratio, and GCS improved after RRT initiation. When renal scoring systems were compared with each other KDIGO was associated with the RIFLE classification and renal SOFA. Conclusion: Many improvements were observed in all AKI patients after RRT but in septic patients, oxygenation and GCS showed better improvement. The mortality rate increased when AKI got complicated with sepsis.
- Open Access
- 25 July 2023
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 16 (4) , 5
Association between Vascular Calcification, Atherosclerosis and Inflammatory Markers in End-stage Renal Disease Patient
Introduction: This study aims to determine the relationship between vascular calcification, carotid artery intima-media thickness (CIMT) and malnutrition with inflammatory parameters in dialysis patients. Materials and Methods: 140 CKD patients and 44 healthy controls were included in the study. CIMT was measured by ultrasonography. Valvular calcification was assessed by echocardiography and vascular calcification scores (VCS) were done based on the radiograms. Biochemical parameters were assessed using routine laboratory methods. Subjective global assessment (SGA) was used to evaluate malnutrition. Results: In the study, VCS showed no differences between hemodialysis (HD) and peritoneal dialysis (PD) patients (1.84±2.35 for HD, 1.77±1.64 for PD; p:0.83). CIMT, Osteopontin (OPN), interleukin-6 (IL-6) and homocysteine were significantly different in both dialysis groups compared to healthy controls. The Mean carotid intima-media thickness (m-CIMT) was higher in HD patients compared to PD group. CIMT, vascular calcification and SGA scores showed positive correlation with age, dialysis duration and valvular calcification grades, and negative correlation with albumin levels. A positive correlation between SGA scores and high-sensitive C-reactive protein (hs-CRP) levels was also noted. On multiple regression analysis, m-CIMT was independently associated with age, VCS and albumin levels. VCS was found to be independently associated with only albumin levels. Conclusion: Vascular and valvular calcification, an indicator of cardiovascular mortality and morbidity in dialysis patients, was found to be significantly associated with malnutrition. We found higher rates of valvular calcification in patients with vascular calcification. Malnutrition was more prominent in these patients.
- 25 July 2023
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 16 (4) , 5
Open AccessAssociation between Vascular Calcification, Atherosclerosis and Inflammatory Markers in End-stage Renal Disease Patient
Introduction: This study aims to determine the relationship between vascular calcification, carotid artery intima-media thickness (CIMT) and malnutrition with inflammatory parameters in dialysis patients. Materials and Methods: 140 CKD patients and 44 healthy controls were included in the study. CIMT was measured by ultrasonography. Valvular calcification was assessed by echocardiography and vascular calcification scores (VCS) were done based on the radiograms. Biochemical parameters were assessed using routine laboratory methods. Subjective global assessment (SGA) was used to evaluate malnutrition. Results: In the study, VCS showed no differences between hemodialysis (HD) and peritoneal dialysis (PD) patients (1.84±2.35 for HD, 1.77±1.64 for PD; p:0.83). CIMT, Osteopontin (OPN), interleukin-6 (IL-6) and homocysteine were significantly different in both dialysis groups compared to healthy controls. The Mean carotid intima-media thickness (m-CIMT) was higher in HD patients compared to PD group. CIMT, vascular calcification and SGA scores showed positive correlation with age, dialysis duration and valvular calcification grades, and negative correlation with albumin levels. A positive correlation between SGA scores and high-sensitive C-reactive protein (hs-CRP) levels was also noted. On multiple regression analysis, m-CIMT was independently associated with age, VCS and albumin levels. VCS was found to be independently associated with only albumin levels. Conclusion: Vascular and valvular calcification, an indicator of cardiovascular mortality and morbidity in dialysis patients, was found to be significantly associated with malnutrition. We found higher rates of valvular calcification in patients with vascular calcification. Malnutrition was more prominent in these patients.
- 1 February 2023
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 21 (2) , 116-122
Factors Influencing Lymphocele Development After Kidney Transplant: Single Center Experience
Objectives: Lymphocele is a well-known postoperative surgical complication after kidney transplant. In this study, our aim was to analyze incidence, risk factors, and outcomes of posttransplant lymphocele in a large cohort. Materials and Methods: This observational study included 395 consecutive patients (219 males and 176 females) who underwent kidney transplant procedures from 183 living and 212 deceased donors in our center between January 2007 and 2014. A lymphocele was diagnosed with ultrasonography. Results: The incidence of lymphoceles in our cohort was 31.9% (n = 126). There were no significant differences with regard to body mass indexes, age of donors, deceased donor ratios, acute rejection episodes, and history of abdominal surgery between those with and without lymphoceles. The pretransplant serum albumin levels (3.29 +/- 0.67 vs 3.48 +/- 0.69 g/dL; P = .009) in the lymphocele group and diabetes mellitus ratios (15.9% vs 4.5%; P < .001) in the nonlymphocele group were lower than levels shown in the other group. The lymphocele ratio in patients who received cyclosporine was higher than that shown in patients who did not received it (37.5% vs. 27.4%; P = .032). There was no difference in lymphocele incidence between patients who were taking and those who were not taking mammalian target of rapamycin inhibitors, mycophenolate mofetil, or mycophenolate sodium. In regression analysis, presence of diabetes mellitus, transplant from deceased donors, older age of donors, and lower albumin levels were independent risk factors for posttransplant lymphocele occurrence. Conclusions: Posttransplant lymphocele was a relatively common surgical complication in our cohort. We concluded that diabetes mellitus, use of kidneys from deceased donors, older donor age, and hypoalbuminemia were independent risk factors for lymphocele development.
- 1 February 2023
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 21 (2) , 116-122
Factors Influencing Lymphocele Development After Kidney Transplant: Single Center Experience
Objectives: Lymphocele is a well-known postoperative surgical complication after kidney transplant. In this study, our aim was to analyze incidence, risk factors, and outcomes of posttransplant lymphocele in a large cohort. Materials and Methods: This observational study included 395 consecutive patients (219 males and 176 females) who underwent kidney transplant procedures from 183 living and 212 deceased donors in our center between January 2007 and 2014. A lymphocele was diagnosed with ultrasonography. Results: The incidence of lymphoceles in our cohort was 31.9% (n = 126). There were no significant differences with regard to body mass indexes, age of donors, deceased donor ratios, acute rejection episodes, and history of abdominal surgery between those with and without lymphoceles. The pretransplant serum albumin levels (3.29 +/- 0.67 vs 3.48 +/- 0.69 g/dL; P = .009) in the lymphocele group and diabetes mellitus ratios (15.9% vs 4.5%; P < .001) in the nonlymphocele group were lower than levels shown in the other group. The lymphocele ratio in patients who received cyclosporine was higher than that shown in patients who did not received it (37.5% vs. 27.4%; P = .032). There was no difference in lymphocele incidence between patients who were taking and those who were not taking mammalian target of rapamycin inhibitors, mycophenolate mofetil, or mycophenolate sodium. In regression analysis, presence of diabetes mellitus, transplant from deceased donors, older age of donors, and lower albumin levels were independent risk factors for posttransplant lymphocele occurrence. Conclusions: Posttransplant lymphocele was a relatively common surgical complication in our cohort. We concluded that diabetes mellitus, use of kidneys from deceased donors, older donor age, and hypoalbuminemia were independent risk factors for lymphocele development.
- Open Access
- 19 November 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-17
The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
Background: This study was designed to investigate the effect of calcineurin inhibitors (CNIs), cyclosporine (CsA), and tacrolimus (Tac) on anthropometrics in kidney transplant recipients. Methods: 111 of 128 adult kidney transplant recipients who received post-transplant CNIs were included in this retrospective study. Anthropometrics were recorded in the pre-transplant and post-transplant 4-year follow-up periods (1st, 3rd, 6th, 12th, 24th, 36th and 48th months). Results: Compared to pre-transplant values, significant increases in body weight and body mass index (between 3rd and 48th months), waist and hip circumferences (between 1st and 48th months), waist-to-hip ratio (between 1st and 3rd or 6th months) and neck circumference (between 1st and 12th or 24th months) were observed in both CsA and Tac groups. A significant increase was noted in post-transplant body fat percentage values for the 3rd to 24th months in the CsA group, whereas for the 24th to 48th months in both CsA and Tac groups. Hip circumferences percentage changes from the pre-transplant period to the 1st, 12th and 24th months were significantly higher in CsA than in the Tac group. At each time point, there was no significant difference in percentage changes for other anthropometric parameters between the CsA and Tac groups. De novo diabetes mellitus developed in 8.3% of the CsA group and 19.1% of the Tac group. Conclusions: After a successful kidney transplant, anthropometric measurements increase in most recipients. Although the effect of calcineurin inhibitor type on weight gain is unclear, a regression analysis showed that CNI type was not a risk factor for the development of obesity in the 48th month. However, it is helpful to be cautious about its dyslipidemic effect in patients using CsA and the potential hazards of using Tac in patients with a diabetic predisposition.
- 19 November 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-17
Open AccessThe effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
Background: This study was designed to investigate the effect of calcineurin inhibitors (CNIs), cyclosporine (CsA), and tacrolimus (Tac) on anthropometrics in kidney transplant recipients. Methods: 111 of 128 adult kidney transplant recipients who received post-transplant CNIs were included in this retrospective study. Anthropometrics were recorded in the pre-transplant and post-transplant 4-year follow-up periods (1st, 3rd, 6th, 12th, 24th, 36th and 48th months). Results: Compared to pre-transplant values, significant increases in body weight and body mass index (between 3rd and 48th months), waist and hip circumferences (between 1st and 48th months), waist-to-hip ratio (between 1st and 3rd or 6th months) and neck circumference (between 1st and 12th or 24th months) were observed in both CsA and Tac groups. A significant increase was noted in post-transplant body fat percentage values for the 3rd to 24th months in the CsA group, whereas for the 24th to 48th months in both CsA and Tac groups. Hip circumferences percentage changes from the pre-transplant period to the 1st, 12th and 24th months were significantly higher in CsA than in the Tac group. At each time point, there was no significant difference in percentage changes for other anthropometric parameters between the CsA and Tac groups. De novo diabetes mellitus developed in 8.3% of the CsA group and 19.1% of the Tac group. Conclusions: After a successful kidney transplant, anthropometric measurements increase in most recipients. Although the effect of calcineurin inhibitor type on weight gain is unclear, a regression analysis showed that CNI type was not a risk factor for the development of obesity in the 48th month. However, it is helpful to be cautious about its dyslipidemic effect in patients using CsA and the potential hazards of using Tac in patients with a diabetic predisposition.
- Open Access
- 29 June 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (6) , 792-796
Serum Prealbumin: a potential predictor of Right Ventricular Dysfunction in patients receiving programmed hemodialysis
OBJECTIVE: Prealbumin has been a reliable marker to predict protein energy malnutrition and hypercatabolic state. In this analysis, we particularly aimed to investigate the potential association between serum prealbumin levels and right ventricular dysfunction in patients receiving programmed hemodialysis. METHODS: A total of 57 subjects were included in the analysis. The subjects were then categorized into two groups: right ventricular dysfunction (n=18) and non-right ventricular dysfunction (n=39) groups. In all patients, detailed transthoracic echocardiography (following hemodialysis) were performed along with the evaluation of complete blood count, routine biochemistry parameters, and, in particular, serum prealbumin levels. RESULTS: Mortality rate at 3 years was found to be significantly higher in the right ventricular dysfunction group (p=0.042). Serum prealbumin levels were also significantly lower in the right ventricular dysfunction group compared with the non-right ventricular dysfunction group (23.83??8.50 mg/dL versus 31.38??6.81 mg/dL, p=0.001). In the receiver operating characteristics curve analysis, a prealbumin cutoff value of <28.5 mg/dL was found to predict right ventricular dysfunction, with a sensitivity of 67% and a specificity of 62% (area under the curve: 0.744). In the correlation analysis, a moderate yet significant positive correlation was demonstrated between serum prealbumin and tricuspid annular plane systolic excursion (r=0.365, p=0.005). CONCLUSION: This study suggests that low serum prealbumin might serve as a potential predictor of right ventricular dysfunction (and its clinical consequences) in patients receiving programmed hemodialysis.
- 29 June 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (6) , 792-796
Open AccessSerum Prealbumin: a potential predictor of Right Ventricular Dysfunction in patients receiving programmed hemodialysis
OBJECTIVE: Prealbumin has been a reliable marker to predict protein energy malnutrition and hypercatabolic state. In this analysis, we particularly aimed to investigate the potential association between serum prealbumin levels and right ventricular dysfunction in patients receiving programmed hemodialysis. METHODS: A total of 57 subjects were included in the analysis. The subjects were then categorized into two groups: right ventricular dysfunction (n=18) and non-right ventricular dysfunction (n=39) groups. In all patients, detailed transthoracic echocardiography (following hemodialysis) were performed along with the evaluation of complete blood count, routine biochemistry parameters, and, in particular, serum prealbumin levels. RESULTS: Mortality rate at 3 years was found to be significantly higher in the right ventricular dysfunction group (p=0.042). Serum prealbumin levels were also significantly lower in the right ventricular dysfunction group compared with the non-right ventricular dysfunction group (23.83??8.50 mg/dL versus 31.38??6.81 mg/dL, p=0.001). In the receiver operating characteristics curve analysis, a prealbumin cutoff value of <28.5 mg/dL was found to predict right ventricular dysfunction, with a sensitivity of 67% and a specificity of 62% (area under the curve: 0.744). In the correlation analysis, a moderate yet significant positive correlation was demonstrated between serum prealbumin and tricuspid annular plane systolic excursion (r=0.365, p=0.005). CONCLUSION: This study suggests that low serum prealbumin might serve as a potential predictor of right ventricular dysfunction (and its clinical consequences) in patients receiving programmed hemodialysis.
- Open Access
- 3 September 2021
- Published by The European Research Journal in The European Research Journal
- Vol. 7 (5) , 495-500
The incidence of hypophosphatemia in the early posttransplant period in renal transplant recipients and its association with graft function
Objectives: To investigate the prevalence of posttransplant hypophosphatemia in the early posttransplant period among renal transplant recipients in relation to its impact on renal graft function. Methods: A total of 78 renal transplant recipients who were transplanted between January 2016 and March 2020 were included in this retrospective single center study. Data on laboratory findings (phosphate, creatinine, estimated glomerular filtration rate [eGFR], albumin, serum corrected calcium and parathyroid hormone [PTH] levels) at pre- and posttransplant 3 month follow up period were recorded. Results: Hypophosphatemia was detected in 16 (20.8%), 13 (16.7%) and 7 (9.1%) patients at the posttransplant day 10, month 1 and month 3, respectively. Posttransplant day 10 and day 30 measurements revealed significantly lower serum creatinine values (p < 0.001 and p < 0.07, respectively) and significantly higher eGFR values (p = 0.009 and p = 0.036, respectively) in the hypophosphatemic group compared to the normophosphatemic group. Serum phosphate displayed linear relationship with creatinine at day 10 (r=0.687, p < 0.001), day 30 (r=0.301, p = 0.007), while not correlated with PTH levels at posttransplant day 10, day 30 and day 90. Conclusions: Our findings suggest that hypophosphatemia is common in the early posttransplant period, particularly first month after kidney transplantation, being associated with better renal graft function.
- 3 September 2021
- Published by The European Research Journal in The European Research Journal
- Vol. 7 (5) , 495-500
Open AccessThe incidence of hypophosphatemia in the early posttransplant period in renal transplant recipients and its association with graft function
Objectives: To investigate the prevalence of posttransplant hypophosphatemia in the early posttransplant period among renal transplant recipients in relation to its impact on renal graft function. Methods: A total of 78 renal transplant recipients who were transplanted between January 2016 and March 2020 were included in this retrospective single center study. Data on laboratory findings (phosphate, creatinine, estimated glomerular filtration rate [eGFR], albumin, serum corrected calcium and parathyroid hormone [PTH] levels) at pre- and posttransplant 3 month follow up period were recorded. Results: Hypophosphatemia was detected in 16 (20.8%), 13 (16.7%) and 7 (9.1%) patients at the posttransplant day 10, month 1 and month 3, respectively. Posttransplant day 10 and day 30 measurements revealed significantly lower serum creatinine values (p < 0.001 and p < 0.07, respectively) and significantly higher eGFR values (p = 0.009 and p = 0.036, respectively) in the hypophosphatemic group compared to the normophosphatemic group. Serum phosphate displayed linear relationship with creatinine at day 10 (r=0.687, p < 0.001), day 30 (r=0.301, p = 0.007), while not correlated with PTH levels at posttransplant day 10, day 30 and day 90. Conclusions: Our findings suggest that hypophosphatemia is common in the early posttransplant period, particularly first month after kidney transplantation, being associated with better renal graft function.
- Open Access
- 31 March 2021
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 46 (1) , 266-272
The impact of ferric carboxymaltose treatment on serum phosphorus levels in chronic kidney disease
Amaç: Çalışmamızda kronik böbrek hastalarında Ferrik karboksimaltoz (FKM) replasmanının başta fosfor olmak üzere mineral metabolizma parametreleri ve anemi profili üzerindeki etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Eylül 2018 ve Mart 2020 tarihleri arasında kronik böbrek hastalığı nedeniyle takip edilen ve demir eksikliği anemisi nedeniyle FKM tedavisi verilmiş 59 hasta çalışmaya dahil edilmiştir. Tüm hastalara FKM tek doz 1000mg olarak verilmiş, tedavi öncesi ve tedavi sonrası 1. ay ve 3. ay laboratuvar tetkikleri değerlendirilmiştir. Bulgular: Tedavi öncesi ortalama serum fosfor düzeyi 3.82±0.65 mg/dL, hemoglobin değeri 11.19±1.55 g/dL ve ferritin düzeyi 25.70 (11.90-54.70) µg/L bulunmuştur. FKM replasmanı sonrası 1. ayda 19 hastada (%32.2) hipofosfatemi gelişmiştir ve serum fosfor düzeyinde başlangıca göre ortalama %17.8 oranında düşüş izlenirken kalsiyum, PTH, 25(OH)D vitamini, kreatinin ve eGFR düzeylerinde anlamlı değişiklik olmamıştır. Hiçbir hastada FKM ilişkili yan etki gözlenmemiştir. Tedavi sonrası 3. ayda 25 hastada (%42.3) hemoglobin değeri ≥1 g/dL artış göstermiştir. Sonuç: Diyalize girmeyen kronik böbrek hastalarında demir eksikliği anemisi tedavisinde FKM iyi tolere edilen ve hızlı etki gösteren bir parenteral tedavi seçeneğidir. Sıklıkla asemptomatik ve geçici olarak ortaya çıkan hipofosfatemi önemsiz ve tedavi kararını etkilemeyecek bir yan etki olarak kabul edilebilir.
- 31 March 2021
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 46 (1) , 266-272
Open AccessThe impact of ferric carboxymaltose treatment on serum phosphorus levels in chronic kidney disease
Amaç: Çalışmamızda kronik böbrek hastalarında Ferrik karboksimaltoz (FKM) replasmanının başta fosfor olmak üzere mineral metabolizma parametreleri ve anemi profili üzerindeki etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Eylül 2018 ve Mart 2020 tarihleri arasında kronik böbrek hastalığı nedeniyle takip edilen ve demir eksikliği anemisi nedeniyle FKM tedavisi verilmiş 59 hasta çalışmaya dahil edilmiştir. Tüm hastalara FKM tek doz 1000mg olarak verilmiş, tedavi öncesi ve tedavi sonrası 1. ay ve 3. ay laboratuvar tetkikleri değerlendirilmiştir. Bulgular: Tedavi öncesi ortalama serum fosfor düzeyi 3.82±0.65 mg/dL, hemoglobin değeri 11.19±1.55 g/dL ve ferritin düzeyi 25.70 (11.90-54.70) µg/L bulunmuştur. FKM replasmanı sonrası 1. ayda 19 hastada (%32.2) hipofosfatemi gelişmiştir ve serum fosfor düzeyinde başlangıca göre ortalama %17.8 oranında düşüş izlenirken kalsiyum, PTH, 25(OH)D vitamini, kreatinin ve eGFR düzeylerinde anlamlı değişiklik olmamıştır. Hiçbir hastada FKM ilişkili yan etki gözlenmemiştir. Tedavi sonrası 3. ayda 25 hastada (%42.3) hemoglobin değeri ≥1 g/dL artış göstermiştir. Sonuç: Diyalize girmeyen kronik böbrek hastalarında demir eksikliği anemisi tedavisinde FKM iyi tolere edilen ve hızlı etki gösteren bir parenteral tedavi seçeneğidir. Sıklıkla asemptomatik ve geçici olarak ortaya çıkan hipofosfatemi önemsiz ve tedavi kararını etkilemeyecek bir yan etki olarak kabul edilebilir.